Influenza: Advances in Diagnosis and Management
This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complicati...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Singapore
Springer Singapore
2021
|
| Ausgabe: | 1st edition |
| Schriftenreihe: | Respiratory Disease Series: Diagnostic Tools and Disease Managements
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe |
| Beschreibung: | Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- - 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- - 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance? |
| Beschreibung: | 1 Online-Ressource (IX, 229 Seiten) Illustrationen |
| ISBN: | 9789811591099 |
| DOI: | 10.1007/978-981-15-9109-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046997454 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201113s2021 |||| o||u| ||||||eng d | ||
| 020 | |a 9789811591099 |9 978-981-159-109-9 | ||
| 024 | 7 | |a 10.1007/978-981-15-9109-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-981-15-9109-9 | ||
| 035 | |a (OCoLC)1220925144 | ||
| 035 | |a (DE-599)BVBBV046997454 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 | ||
| 082 | 0 | |a 616.9 | |
| 245 | 1 | 0 | |a Influenza |b Advances in Diagnosis and Management |c edited by Jiro Fujita |
| 250 | |a 1st edition | ||
| 264 | 1 | |a Singapore |b Springer Singapore |c 2021 | |
| 300 | |a 1 Online-Ressource (IX, 229 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Respiratory Disease Series: Diagnostic Tools and Disease Managements | |
| 500 | |a Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- | ||
| 500 | |a - 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- | ||
| 500 | |a - 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance? | ||
| 520 | |a This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe | ||
| 650 | 4 | |a Infectious diseases | |
| 650 | 4 | |a Respiratory organs-Diseases | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Vaccines | |
| 650 | 4 | |a Health promotion | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 700 | 1 | |a Fujita, Jiro |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789811591082 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789811591105 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789811591112 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-15-9109-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME |a ZDB-2-SXM | ||
| 940 | 1 | |q ZDB-2-SME_2021_Fremddaten | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032405178 | ||
| 966 | e | |u https://doi.org/10.1007/978-981-15-9109-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_2021_Fremddaten |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804181943970955264 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Fujita, Jiro |
| author2_role | edt |
| author2_variant | j f jf |
| author_facet | Fujita, Jiro |
| building | Verbundindex |
| bvnumber | BV046997454 |
| collection | ZDB-2-SME ZDB-2-SXM |
| ctrlnum | (ZDB-2-SME)978-981-15-9109-9 (OCoLC)1220925144 (DE-599)BVBBV046997454 |
| dewey-full | 616.9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9 |
| dewey-search | 616.9 |
| dewey-sort | 3616.9 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1007/978-981-15-9109-9 |
| edition | 1st edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05233nmm a2200517zc 4500</leader><controlfield tag="001">BV046997454</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201113s2021 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811591099</subfield><subfield code="9">978-981-159-109-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-981-15-9109-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-981-15-9109-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220925144</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046997454</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Influenza</subfield><subfield code="b">Advances in Diagnosis and Management</subfield><subfield code="c">edited by Jiro Fujita</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore</subfield><subfield code="b">Springer Singapore</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (IX, 229 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Respiratory Disease Series: Diagnostic Tools and Disease Managements</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance?</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Respiratory organs-Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health promotion</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fujita, Jiro</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789811591082</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789811591105</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789811591112</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-981-15-9109-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield><subfield code="a">ZDB-2-SXM</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2021_Fremddaten</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032405178</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-981-15-9109-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_2021_Fremddaten</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV046997454 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T15:55:36Z |
| indexdate | 2024-07-10T08:59:42Z |
| institution | BVB |
| isbn | 9789811591099 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032405178 |
| oclc_num | 1220925144 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-578 |
| physical | 1 Online-Ressource (IX, 229 Seiten) Illustrationen |
| psigel | ZDB-2-SME ZDB-2-SXM ZDB-2-SME_2021_Fremddaten ZDB-2-SME ZDB-2-SME_2021_Fremddaten |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Springer Singapore |
| record_format | marc |
| series2 | Respiratory Disease Series: Diagnostic Tools and Disease Managements |
| spelling | Influenza Advances in Diagnosis and Management edited by Jiro Fujita 1st edition Singapore Springer Singapore 2021 1 Online-Ressource (IX, 229 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Respiratory Disease Series: Diagnostic Tools and Disease Managements Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- - 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- - 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance? This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe Infectious diseases Respiratory organs-Diseases Immunology Vaccines Health promotion (DE-588)4143413-4 Aufsatzsammlung gnd-content Fujita, Jiro edt Erscheint auch als Druck-Ausgabe 9789811591082 Erscheint auch als Druck-Ausgabe 9789811591105 Erscheint auch als Druck-Ausgabe 9789811591112 https://doi.org/10.1007/978-981-15-9109-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Influenza Advances in Diagnosis and Management Infectious diseases Respiratory organs-Diseases Immunology Vaccines Health promotion |
| subject_GND | (DE-588)4143413-4 |
| title | Influenza Advances in Diagnosis and Management |
| title_auth | Influenza Advances in Diagnosis and Management |
| title_exact_search | Influenza Advances in Diagnosis and Management |
| title_exact_search_txtP | Influenza Advances in Diagnosis and Management |
| title_full | Influenza Advances in Diagnosis and Management edited by Jiro Fujita |
| title_fullStr | Influenza Advances in Diagnosis and Management edited by Jiro Fujita |
| title_full_unstemmed | Influenza Advances in Diagnosis and Management edited by Jiro Fujita |
| title_short | Influenza |
| title_sort | influenza advances in diagnosis and management |
| title_sub | Advances in Diagnosis and Management |
| topic | Infectious diseases Respiratory organs-Diseases Immunology Vaccines Health promotion |
| topic_facet | Infectious diseases Respiratory organs-Diseases Immunology Vaccines Health promotion Aufsatzsammlung |
| url | https://doi.org/10.1007/978-981-15-9109-9 |
| work_keys_str_mv | AT fujitajiro influenzaadvancesindiagnosisandmanagement |